Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Prolonged Heparin Re-Exposure in a Patient With Previous Heparin-Induced Thrombocytopenia (HIT).
Journal: International journal of laboratory hematology
Published: May 21, 2025
Interruption of BTK inhibitor improves response to SARS-CoV-2 booster vaccination in patients with CLL.
Journal: Leukemia & lymphoma
Published: September 21, 2023
BTK inhibitors impair humoral and cellular responses to recombinant zoster vaccine in CLL.
Journal: Blood advances
Published: November 09, 2021
COVID-19 vaccines for patients with haematological conditions.
Journal: The Lancet. Haematology
Published: March 09, 2021
Risk-adapted, ofatumumab-based chemoimmunotherapy and consolidation in treatment-naïve chronic lymphocytic leukemia: a phase 2 study.
Journal: Leukemia & lymphoma
Published: March 03, 2021
A phase II study of ibrutinib and short-course fludarabine in previously untreated patients with chronic lymphocytic leukemia.
Journal: American journal of hematology
Published: August 10, 2020
Reconstitution of humoral immunity and decreased risk of infections in patients with chronic lymphocytic leukemia treated with Bruton tyrosine kinase inhibitors.
Journal: Leukemia & lymphoma
Published: June 09, 2020
Immunological changes with kinase inhibitor therapy for chronic lymphocytic leukemia.
Journal: Leukemia & lymphoma
Published: May 17, 2018
Showing 1-11 of 11
Last Updated: 09/26/2026